← Back to Search

Participants Reviewed by ETB for Pediatric Cancer

N/A
Recruiting
Led By Jonathan Metts, MD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to up to 60 months from end of therapy
Awards & highlights

Summary

To evaluate the ability of a multidisciplinary and multisite group, the Pediatric Evolutionary Tumor Board (pedsETB), to develop additional therapeutic strategies in patients without curative options or with suboptimal outcomes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to up to 60 months from end of therapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to up to 60 months from end of therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The feasibility of the pedsETB developing therapeutic strategies

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants Reviewed by ETBExperimental Treatment1 Intervention
Participants clinical history, available therapeutic options, and outcome expectations will be presented to the Evolutionary Tumor Board (ETB) along with images and pathology. Strategies and models will be presented regarding additional evolutionary ideas that can be applied. These ideas will be characterized (e.g. first strike-second strike, adaptive, novel sequential therapy, novel combination, novel dosing schedule, etc.).

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
549 Previous Clinical Trials
135,675 Total Patients Enrolled
National Pediatric Cancer FoundationOTHER
5 Previous Clinical Trials
197 Total Patients Enrolled
Jonathan Metts, MDPrincipal InvestigatorMoffitt Cancer Center
3 Previous Clinical Trials
82 Total Patients Enrolled
~23 spots leftby Apr 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top